Maternal obesity is associated with phenotypic alterations in fetal immune cells by single-cell mass cytometry

Elizabeth Ann L Enninga1, Jin Sung Jang2,3, Benjamin Hur4,5

  • 1Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.

Insights

Maternal obesity alters fetal immune cell development. Infants born to obese mothers show increased CD4+ T cells and decreased myeloid cells, indicating a link between maternal body mass index and infant immunity.

Area of Science:

  • Immunology
  • Perinatal Medicine
  • Developmental Biology

Background:

  • Maternal obesity during pregnancy poses risks to offspring health.
  • The impact of maternal obesity on fetal immune system development at a cellular level is not well understood.

Purpose of the Study:

  • To investigate the effects of maternal obesity on fetal immune cell populations and phenotypes.
  • To characterize cellular-level immune alterations in newborns exposed to maternal metabolic dysregulation.

Main Methods:

  • Single-cell mass cytometry (CyTOF) was used to analyze cord blood mononuclear cells (CBMCs) from infants of mothers with high BMI (>25kg/m²) versus normal BMI (18-25kg/m²).
  • CBMCs were matched for confounding variables, and statistical analyses were adjusted for fetal sex.
  • Data analysis was performed using viSNE and FlowSOM software.

Main Results:

  • Significant alterations in immune cell populations were observed in newborns from mothers with high BMI.
  • Specifically, there were increases in CD4+ T cells and decreases in myeloid cell populations.
  • Elevated concentrations of IL-12p40 and MDC were found in the high BMI group.

Conclusions:

  • Maternal obesity is associated with significant changes in fetal immunity.
  • These findings highlight the need for long-term monitoring of immunologic outcomes and clinical risks in children born to mothers with high pre-pregnancy BMI.
Abstract